Shaping the Future Of Biotech
Full-Service CRO Excellence
Scientific Proficiency at the Core of Trials
Transcending Global Boundaries
Paving the Path to Regulatory Success
Capabilities
Comprehensive CRO capabilities spanning early to late-phase clinical development, supported by global operations, scientific expertise, and regulatory alignment.
Therapeutic Excellence
Advancing vital therapies across diverse therapeutic areas
Accelerating Biosimilar Development
Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.
End-to-End Solutions
Full-service CRO Capabilities
Analytical Excellence
State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More
Accelerating Biosimilar Development
Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.
End-to-End Solutions
Full-service offerings from Preclinical to Regulatory Support
Analytical Excellence
State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More
Why Lambda?
We combine comprehensive capabilities and global reach to support biotech and pharmaceutical companies with customized clinical development and resource solutions.
A Truly Global CRO with Multi-continental Presence
Comprehensive Clinical Research Services
Best Credit rating in CRO Industry
Strong Leadership with 20+ years of Experience
A Truly Global CRO with Multi-continental Presence
Comprehensive Clinical Research Services
Best Credit rating in CRO Industry
Strong Leadership with 20+ years of Experience
‘Regulatory & Compliance Excellence Award’ at the CPHI Pharma Awards 2023 for the exceptional work by Lambda in ‘Enhancing Compliance & Data Generation in Clinical Trials through Advanced Software Solutions and EDC Platform.’
‘Industry Partner of the Year’ Award
Global Generics & Biosimilar Awards 2023
Globally Recognized for Research Excellence
‘Regulatory & Compliance Excellence Award’ at the CPHI Pharma Awards 2023 for exceptional work in ‘Enhancing Compliance & Data Generation in Clinical Trials through Advanced Software Solutions and EDC Platform.’
‘Industry Partner of the Year’ at the Global Generics & Biosimilars Awards 2023, recognising our innovative testing methods for biosimilars, novel approaches, and commitment to exceeding regulatory expectations from esteemed global agencies like the USFDA & EMA.
Featured Research and Insights
Our Presence
We are aggressively expanding globally and are confident in our research initiatives, propelling us toward a trajectory of excellence.
Corporate Office – Ahmedabad
Lambda House, Plot No. 38,
Survey No. 388, Near Silver Oak University,
S.G. Highway, Gota, Ahmedabad - 382481,
Gujarat, India.
Representative Office
Poland (Warsaw)
Representative Office
UK (London)
Representative Office
Canada (Toronto)
Representative Office
US (Las Vegas)
Representative Office
Spain (Barcelona)